Literature DB >> 1726638

Focussed extracorporeal pyrotherapy: experimental results.

G Vallancien1, E Chartier-Kastler, D Chopin, B Veillon, J M Brisset, J André-Bougaran.   

Abstract

A new device made of piezoelectric ceramic placed in a semispherical dish and focussed at 320 mm was developed in order to generate heat and cavitation responsible for coagulative necrosis of deep tissues. The target to be treated is located with a central ultrasound probe of 3.5 MHz. In vitro studies with polyurethane phantoms showed that the ultrasound melted a surface of 2 x 12 mm within 1 s. The temperature recorded at the focus was 270 degrees C. In tissue samples (prostate cancer and benign prostate hyperplasia), the temperature rose to 85 degrees C in vitro and a hyperechoic zone appeared at the focus during shots. In vivo 8-mm plastic spheres, introduced surgically into the bladder of pigs, were melted by repeat shots without burning of crossed tissues. These studies were performed in the kidney and the liver. Autopsy performed on day 0 showed congestion, autopsy performed between day 6 and day 11 showed necrosis, whereas at 3 months the focussed area was fibrosed. This technique, which we called 'focussed extracorporeal pyrotherapy', combines phenomena of cavitation and high heat at the focus. Prostate tumors, bladder tumors, kidney tumors and liver metastases are potential indications for pyrotherapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726638     DOI: 10.1159/000471702

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

2.  An experimental high energy therapeutic ultrasound equipment: design and characterisation.

Authors:  T Kirkhorn; L O Almquist; H W Persson; N G Holmer
Journal:  Med Biol Eng Comput       Date:  1997-05       Impact factor: 2.602

3.  [HIFU in urological oncology].

Authors:  S Thüroff; C Chaussy
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

Review 4.  [Transrectal high-intensity focused ultrasound for local treatment of prostate cancer. 2009 Update].

Authors:  C G Chaussy; S Thüroff
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

5.  Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses.

Authors:  Regina El Dib; Naji J Touma; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2009-04       Impact factor: 1.862

6.  Review of the efficacy and safety of cryoablation for the treatment of small renal masses.

Authors:  Anil Kapoor; Naji J Touma; Regina El Dib
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

7.  Focused ultrasound development and clinical adoption: 2013 update on the growth of the field.

Authors:  Dasha Tyshlek; Jean-Francois Aubry; Gail Ter Haar; Arik Hananel; Jessica Foley; Matthew Eames; Neal Kassell; Heather Huff Simonin
Journal:  J Ther Ultrasound       Date:  2014-02-27

8.  Radiofrequency ablation and cryoablation of renal tumours.

Authors:  K G Kwan; E D Matsumoto
Journal:  Curr Oncol       Date:  2007-02       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.